Saturday , December 16 2017
Home / Resources / Featured Writers (page 49)

Featured Writers

FEATURED WRITERS

Time-Lag for CGMS

HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By KuZu & DèSASTRE cokfena.org / sanaltahrip.org HACKED By …

Read More »

USING HUMOR IN DIABETES EDUCATION

Healthcare is a serious business, so using humor as a therapeutic tool to assist people may not be in the forefront of your mind. Theresa L. Garnero has prepared a handout to help us overcome our sometimes over serious manners and learn the necessary skills to use humor.

Read More »

Cardiovascular Risk With Avandia?

With the current New England Journal Article on Avandia and it’s increased risks for cardiovascular problems, I believe we have missed the whole point of the article. Most people only looked at the editorials on the article and not the original article in the New England Journal of Medicine. If …

Read More »

What Does It Take to Break the Cycle?

Sheri_Colberg

Dr. Sheri Colberg, author of The 7 Step Diabetes Fitness Plan: Living Well and Being Fit with Diabetes, has her own take on what Dick and Steve are recommending. Be sure to read What Does It Take to Break the Cycle, and find out more about the best replacement.

Read More »

Misreading Avandia

With all the press last week about Avandia and heart disease, patients have been on the phones to their prescribers asking for a change. Stephen Freed, Publisher, Diabetes Educator and Pharmacist, worked with Dr. Richard K. Bernstein, MD, to find the real message in all the hype. To find out …

Read More »

Insulin Analogues Glargine and Detemir Differ in Duration

Head Shot of Matthew Riddle, Jr., M.D.

Use of the insulin analogues glargine and detemir can result in better glucose control. However, because glargine and detemir differ from one another, further clinical experience may identify which patient groups will do better on each drug. Dr Matthew C. Riddle recently spoke at an American Diabetes Association meeting and …

Read More »